Valeant Pharmaceuticals International Inc $115.95

down -0.33


23/9/2014 04:00 PM  |  NYSE : VRX  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get VRX Trend Analysis - it has underperformed the S&P 500 by 4%

Partner Headlines

  1. Ackman forewarns Allergan

    IBD
  2. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga
  3. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD
  4. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD
  5. Indexes Pare Losses As Salix Soars On Buyout Talk

    IBD
  6. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD
  7. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga
  8. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga
  9. Valeant, Allergan settle suit

    IBD
  10. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD
  11. Ackman's New Fund Could Spur More Market Activism

    IBD
  12. Pershing Square Submiterd Additional Special Meeting Requests On Friday, ...

    Benzinga
  13. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD
  14. William Ackman Sends Letter To Allergen Board

    Benzinga
  15. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD
  16. Valeant Pharmaceuticals Part XII: the rolling solvency calculation

    GuruFocus
  17. Allergan Reports Filing of Answer in Federal Court Related to Valeant, ...

    Benzinga
  18. Hedge Fund Manager Bill Ackman with a Very Profitable Year

    GuruFocus
  19. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  20. IBD's Special 8-Week Hold Rule Has Faced Tough 2014

    IBD
  21. SALIX PHARMACEUTICALS

    IBD
  22. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga
  23. Salix Soars On Allergan Buzz

    IBD
  24. Indexes Rally On Strong Housing Data, Retail Reports

    IBD
  25. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD
  26. Allergan Takes In 13 New Hedge Fund Investments In Q2

    Benzinga
  27. Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension ...

    Benzinga
  28. Benzinga's M&A Chatter for Monday August 11, 2014

    Benzinga
  29. Valeant Pharmaceuticals'

    IBD
  30. Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables

    GuruFocus
  31. Allergan Rebounds After Analyst Upgrades On Valuation

    IBD
  32. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  33. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  34. Thursday's Selling Momentum Continues In To Friday

    Benzinga
  35. Thursday's Selling Momentum Continues Into Friday

    Benzinga
  36. Valeant, Ackman's Pershing Square Issue Response to 'Frivolous Allergan ...

    Benzinga
  37. Valeant Guides Outlook Low

    IBD
  38. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  39. Valeant Q2 Meets Views; Guidance Down On Asset Sale

    IBD
  40. UPDATE: Valeant Pharmaceuticals Posts Higher Q2 Profit

    Benzinga
  41. Stocks End Mixed; Akamai Falls, Yelp Rises After Hours

    IBD
  42. Diamond Hill Capital Comments on Valeant Pharmaceuticals International ...

    GuruFocus
  43. BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

    Benzinga
  44. Allergan EPS Gains Accelerate

    IBD
  45. Allergan Earnings Growth, Job Cuts Counter Valeant

    IBD
  46. UPDATE: Valeant Complains to SEC Regarding Allergan Claims

    Benzinga
  47. Valeant Submits HSR Filing Related to Proposed Allergan Deal

    Benzinga
  48. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  49. Aegis Capital Believes Valeant Pharmaceuticals' Bid For Allergan Is Looking ...

    Benzinga
  50. Chipotle, Keurig Near Buy Points; Energy Dominates

    IBD
Trading Center